GIPM
ORGO icon

G2 Investment Partners Management’s Organogenesis Holdings ORGO Stock Holding History

G2 Investment Partners Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-60,634
Closed -$201K – 98
2023
Q2 		$201K Buy
+60,634
New +$179K 0.05% 85

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

G2 Investment Partners Management's ORGO Position: Q3 2023 in Review

G2 Investment Partners Management sold out of Organogenesis Holdings (ORGO) in Q3 2023, closing a stake of 60,634 shares — an estimated $201K sold.

G2 Investment Partners Management first reported a position in ORGO in Q2 2023 and held it in 1 quarter. The position peaked at $201K in Q2 2023. 104 funds tracked by Wall St. Rank hold ORGO as of Q3 2023.

  • G2 Investment Partners Management reported no remaining Organogenesis Holdings position as of Q3 2023 after selling out during the quarter.
  • G2 Investment Partners Management sold 60,634 Organogenesis Holdings shares in Q3 2023, an estimated $201K.
  • G2 Investment Partners Management first reported a position in Organogenesis Holdings in Q2 2023 and held it in 1 quarter.
  • G2 Investment Partners Management's Organogenesis Holdings position peaked at $201K in Q2 2023.
  • 104 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2023.

Based on G2 Investment Partners Management's 13F filing for Q3 2023, filed 14 Nov 2023.